REGENXBIO
RGNX
HK$66.01
Share price
-4.32%
Change (1 day)
-41.12%
Change (1 year)
Categories
REGENXBIO (RGNX) - Total liabilities
Total liabilities on the balance sheet as of March 2025 : HK$1.70 Billion
According to REGENXBIO's latest financial reports the company's total liabilities are HK$1.70 Billion. A company’s total liabilities is the sum of all current and non-current debts and obligations.
REGENXBIO - Total liabilities on balance sheet (from 2014 to 2025)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2024-12-31 | HK$1.60 B | -21.78% |
| 2023-12-31 | HK$2.04 B | -17.33% |
| 2022-12-31 | HK$2.47 B | -9.12% |
| 2021-12-31 | HK$2.72 B | 6.43% |
| 2020-12-31 | HK$2.56 B | 589.33% |
| 2019-12-31 | HK$0.37 B | 35.7% |
| 2018-12-31 | HK$0.27 B | 123.97% |
| 2017-12-31 | HK$0.12 B | 43.39% |
| 2016-12-31 | HK$85.26 M | 140.6% |
| 2015-12-31 | HK$35.43 M | -50.28% |
| 2014-12-31 | HK$71.27 M | 97.54% |
| 2013-12-31 | HK$36.08 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | HK$0.18 B | -89.33% | 🇺🇸 USA |